# Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

> **NCT01909492** · — · COMPLETED · sponsor: **Providence Health & Services** · enrollment: 30 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **PROCEDURE:** Blood Draw
- **PROCEDURE:** Lumbar Puncture

## Key facts

- **NCT ID:** NCT01909492
- **Lead sponsor:** Providence Health & Services
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-20
- **Primary completion:** 2023-10-05
- **Final completion:** 2023-10-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-06-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01909492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01909492, "Measurement of Relaxin Peptide in Multiple Sclerosis (MS)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01909492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*